Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache
JERUSALEM–(BUSINESS WIRE)–Jun. 15, 2018– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a change in the clinical development […]
Teva